Vés al contingut

Comprehensive assessment of erenumab efficacy in subjects with high frequency episodic migraine with at least 1 previously failed preventive treatment: a clobal, double-blind, placebo-controlled phase 4 study.

Obert
  • Codi protocol: 20190008
  • Codi EudraCT: 2019-003646-33
  • Grup de recerca: Cefalea i dolor neurològic
  • Servei: Neurologia
  • Investigador/a principal:  Pozo Rosich, Patricia
  • Malaltia: Malalties del sistema nerviós
  • Fase: Fase IV
  • Estat: Reclutant voluntaris